Author

Fazal Hadi

AstraZeneca (United Kingdom)ORCID 0000-0003-3553-817XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Fazal Hadi1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrian V. LeeiD· 1 shared Clive S. D’SantosiD· 1 shared Danielle Tseng· 1 shared Donald Patrick McDonnelliD· 1 shared Fangyuan CheniD· 1 shared Jason GertziD· 1 shared Jason S. CarrolliD· 1 shared Jiebin Liu· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian V. LeeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer Biologynpj Breast CancerPeer-reviewedDec 19, 2024

EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancer

Zheqi Li, Fangyuan Chen, Li Chen…·Adrian V. Lee

EstroGene2.0 is a multi-omic database that compiles data on estrogen receptor responses and resistance in breast cancer, revealing diverse transcriptomic changes and identifying key targets.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky